Keloid Clinical Trial - Surgical Excision & Intralesional Steroid

Status Completed

Clinical Trial Summary

Two groups of patients (73 patients each) undergoing routine caesarean section has recurrent keloid at site of surgical scar. One group will undergo surgical excision of keloid. The other group will have combined surgical excision of keloid and single intralesional dexamethasone injection at edges of wound.All patients were reviewed once per month for 6 months for evidence of recurrence

Clinical Trial Description

One hundred forty six patients that are admitted at Kasr Al Aini teaching university hospital for caesarean section, will be enrolled in this randomized clinical trial after approval by the local ethical health committee. A written informed consent will be obtained from each participant after full explanation of the procedure.

Under general or spinal anaesthesia done routinely during caesarean section, total extralesional surgical excision of the keloid is performed and minimal undermining followed by the usual steps of caesarean section. Primary closure of the wound in layers is achieved in all cases. A running subcuticular prolene 2/0 stitch is used to suture the skin. Group A of 73 patients will not receive further injection. In 73 patients (group B), the wound edges are injected once with dexamethasone. A 1 mL syringe with a 30-gauge needle is used and injection is both intradermal and subdermal. Repeated alternate punctures are used to bathe the wound edges with the drug. Approximately 0.5-1 mL of dexamethasone (4 mg/mL) in wound tissue.

For all patients, the wound is painted with betadine and sealed until postoperative day 14, at which time the subcuticular stitch is removed.

Postoperative medications are given to all patients in the form of analgesics and antibiotics as routinely given at the hospital. All patients were advised to avoid direct sun exposure for the following month. No postoperative applications (eg, compression, steroid injections, etc) were used in any of the patients. All patients were reviewed once per month for 6 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03239964
Study type	Interventional
Source	Kasr El Aini Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	August 10, 2016
Completion date	January 24, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02923596` - Retrospective Study of Keloid Disorder	N/A
Completed	`NCT02922972` - Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT	N/A
Terminated	`NCT01478243` - Study of Psycho-Social Impact of Keloid	N/A
Recruiting	`NCT01423383` - Epidemiology Study of Keloid	N/A
Completed	`NCT03228693` - Gene Expression and Biomarker Profiling of Keloid Skin	N/A
Not yet recruiting	`NCT04326959` - Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid	Phase 1/Phase 2
Recruiting	`NCT03312166` - Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]	N/A
Recruiting	`NCT02823236` - Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars	Phase 3
Recruiting	`NCT04597060` - The Safety and Efficacy of Thermo-mechanical System for Fractional Ablation Associated Triamcinolone Acetonide Drug Delivery for the Treatment of Hypertrophic Scars and Keloids	N/A
Completed	`NCT05887804` - Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial	Phase 4
Completed	`NCT05939817` - The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial	Phase 4
Completed	`NCT03630198` - Pain Outcomes Following Intralesional Corticosteroid Injections	Phase 4
Completed	`NCT04169438` - Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions	N/A
Recruiting	`NCT01423981` - Web Based Investigation of Natural History of Keloid Disorder, an Online Survey	N/A
Completed	`NCT01446770` - Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181	Phase 2
Recruiting	`NCT06138964` - Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars	Phase 3
Enrolling by invitation	`NCT05461157` - Preoperative Silicone Ointment and Wound Healing	N/A
Not yet recruiting	`NCT04593706` - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)	N/A
Active, not recruiting	`NCT04988022` - Dupilumab in the Treatment of Keloids	Phase 4
Withdrawn	`NCT02546076` - Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms